Publication Cover
Journal of Dual Diagnosis
research and practice in substance abuse comorbidity
Volume 17, 2021 - Issue 1
331
Views
7
CrossRef citations to date
0
Altmetric
Psychotherapy & Psychosocial Issues

Impairments in Executive Functioning in Patients with Comorbid Substance Use and Personality Disorders: A Systematic Review

, PhDORCID Icon, , MScORCID Icon, , PhDORCID Icon, , PhDORCID Icon, , PhDORCID Icon, , PhDORCID Icon, , PhDORCID Icon & , PhDORCID Icon show all
Pages 64-79 | Published online: 22 Oct 2020
 

Abstract

Objective

The purpose of this systematic review was to examine the evidence for impaired executive functioning in patients diagnosed with a dual pathology of personality disorder (PD) and substance use disorder, and to identify whether differences exist in comparison to those with a single diagnosis. Methods: A systematic search was conducted to identify studies using measures of executive functioning in patients with PD-substance use disorder dual pathology. Sixteen studies were selected. Results: The results indicate that dual pathology patients with Cluster C personality disorder do not differ from controls, and that the presence of dual pathology does not influence the updating domain of executive functioning. The findings were inconclusive with regard to dual pathology patients with Cluster B personality disorders. Whilst the various studies consistently show that these patients show worse performance than the control groups, here are contradictory results with regard to whether Cluster B personality disorders add more alterations in executive functioning to those that already appear in substance use disorder. Conclusions: The results suggest the need for further research that more adequately controls variables such as time in treatment, medication, and sample size, whilst there is also a need to employ longitudinal designs that include more patients from Clusters A and C.

Disclosure statement

No potential conflict of interest was reported by the author(s).

Additional Supporting Information may be found in the online version of this article at the publisher’s website:

Database via the OVID Platform; 26 September 2018.

Additional information

Funding

This work was supported by the National Drug Strategy, “Ministry of Health, Social Services and Equality” (Spain) under Grant “Q7150008F-2016/034.”

Log in via your institution

Log in to Taylor & Francis Online

PDF download + Online access

  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 53.00 Add to cart

Issue Purchase

  • 30 days online access to complete issue
  • Article PDFs can be downloaded
  • Article PDFs can be printed
USD 273.00 Add to cart

* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.